One program among several. Metabolic health is a starting point, not the whole platform.
Diabetes, obesity, and metabolic dysfunction are where many members start, and GLP-1 therapy is one tool within a larger cardiometabolic program, managed by a physician with a plan for dose, duration, and what comes after.
Prescribed fast. Managed rarely.
GLP-1 and specialty drug spend is accelerating faster than most plans can model or budget for.
Members are often left on medication indefinitely with no structured plan to reassess or taper.
Without a care team monitoring response, side effects go unmanaged and members discontinue on their own.
Medication without nutrition, movement, and behavior support rarely holds once a member stops.
Optimization first. Deprescribing by design.
A physician manages dose and duration the same way they would any other medication: with a plan for tapering off, not just starting on.
Clinical evaluation before prescribing
A physician confirms GLP-1 therapy is the right tool for this member’s labs and history before starting.
Dose titration and side effect management
Ongoing physician oversight to find the lowest effective dose and manage side effects as they arise.
Nutrition and coaching alongside medication
Registered dietitians and health coaches build the habits that hold after medication is reduced.
Documented deprescribing pathway
As labs and habits improve, your physician builds a monitored path to reduce or discontinue medication.
A program that shows up in the pharmacy line.
GLP-1 medication burden reduction
Overall pharmacy cost savings
Pharmacy ROI, autoimmune cohort